That is very important, since the method a protein in the human body folds figures out if a pharmaceutical will be able to bind to that protein and be efficient. In other words, we have to know how these proteins fold if we want a drug to work. Historically, this has actually been an experimental process (tech predictions). Today, Alpha, Fold can forecast protein folding with 92. 4% accuracy. That's going to make it much simpler to develop drugs that do what they're created to do. This was an advancement almost nobody noticed. However it's going to have profound ramifications for curing illness. I predict that Alpha, Fold will be 98% precise by the end of 2021.
And, naturally, there will be a lot of investment opportunities in this area, too. Shifting topics It's going to be an excellent year for bitcoin. I'm bullish on it in 2021 (korean actress). That said, I still believe bitcoin will continue to be volatile. We're close to all-time highs. I wouldn't be shocked if it pulled back possibly significantly prior to going greater - tech stock. I have actually been covering bitcoin for a very long time now. Among the first research reports I ever released was on bitcoin. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
However at the time of that preliminary recommendation, I entitled my report "What's the Big Offer With Bitcoin?" That reveals you where the conversation was at the time. We were primarily educating readers. But that's not the big question any longer. Now we're seeing institutional cash finally take an interest in bitcoin. Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some small, specific niche enterprise. Mass, Mutual is a trusted 170-year-old organization. So consider that. In 5 years, we went from educating readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake.
Which's a huge reason I'm bullish on it this year. tech predictions. Regards, Jeff Brown, Editor, The Bleeding Edge I have a reward prediction 2020 was a record year for IPOs. 552 U.S. companies went public the most in more than twenty years. These business raised a total of $172 billion. That's an all-time high beating the previous yearly record by 43%. I anticipate 2021 will be another record year in IPOs. There are so many great private companies on the verge of hitting the public markets And I've been dealing with a new way for you to invest even before these companies go public.
This opportunity has been constructing over the last few years. I can't wait to inform you everything about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to discover out all the information. Go right here to reserve your area for complimentary.
Emma Walsh here, handling editor of the Journal. Routine Diary readers understand that tech isn't our typical beat (the legacy report predictions). And when it concerns tech investing, we leave it to the experts. The good news is, we have numerous such specialists in our Rolodex. Our coworker Jeff Brown will recognize to our longtime readers. He is among the most accomplished tech investing specialists we understand (diplomatic relations). In fact, he had several triple-digit returns in his Brownstone Research portfolios in 2015. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to have a look at the big picture and anticipate what's just around the corner.
That includes things like 5G networks, biotech, expert system, and far more. These trends are experiencing exponential growth and producing extraordinary chances for financiers. I wish to ensure all our readers are prepared for what's next. And with that in mind, let me draw the image of what I see being available in the next 12 months Our new 5G (fifth-generation) wireless networks are a topic I have actually been covering for years now. jeff brown genome sequencing stock. However regardless of what many readers might think, this is a trend that's just getting begun. Even though the COVID-19 pandemic interrupted supply chains in 2015, a remarkable 250 million 5G-enabled devices were still offered.
And all of this eventually caused Apple postponing the release of the 5G-enabled i, Phone 12 by two months (black sea). Losing two months of production and sales truly affects the number of 5G devices are sold in the fiscal year. When you consider all of that, selling 250 million units is amazing. More significantly, the delays caused by the pandemic produced a load of pent-up demand. Which demand is now going to be pressed into 2021. In fact, I predict that more than 500 million 5G devices will be delivered in 2021 - brownstone research. And that's not my only 5G forecast When I've discussed 5G in the past, I have actually described its 3 various phases.
In Phase 2, 5G gadgets go on sale. 5G phones and other products begin to reach consumers. And in Phase Three, 5G services start to be provided (jeff brown top biotech stock 2021). That's when we start to see applications operating on 5G networks. Consider things like huge multiplayer video games over a mobile phone. That's not possible with 4G. It will be with 5G. And my 2nd 5G prediction for 2021 is that we will start Stage Three by this summer season. This starts something of a virtuous cycle: The majority of people don't truly appreciate the technology. But they will care if there are exciting applications that can just be accessed with a 5G phone.
That results in more 5G apps being established. In fact, 5G is going to open a suite of unbelievable applications: self-driving cars and trucks, the Web of Things, robotic surgical treatment, and more. All of these technologies require 5G. The financial investment opportunities going forward will be huge. Stepping away from 5G, the next crucial innovation I predict in 2021 is CRISPR hereditary editing. CRISPR stands for "clustered frequently interspaced brief palindromic repeat." It's a mouthful. But it is among the most exciting advancements in biotechnology. At a high level, CRISPR is a technology that can modify our genetic makeup as if it were software application.
The program can crash or not function properly. CRISPR uses a comparable concept however with our genetic code. "Typos" in our genome can lead to illness. CRISPR can remedy these "typos." For many years, CRISPR was primarily a niche technology that wasn't well understood. And during that time, there were actually only 3 business operating in this area. However things are changing. CRISPR is no longer simply theoretical. We're seeing real results. We're treating diseases and seeing that this technology just works. And as a result, a "2nd crop" of early-stage CRISPR business is going public and delivering amazing returns. This entire market is effectively a greenfield chance.
There's space for numerous companies to exist in this area. jeff brown investment prediction. And there will be more. That's my prediction for CRISPR in 2021. I anticipate that 2 or three more genetic modifying business will hold their IPOs. Sticking with biotechnology, we are seeing incredible things taking place at the merging of biotech and expert system (AI). Google's AI subsidiary, Deep, Mind, simply announced at the end of 2020 that its newest Alpha, Fold software application can accurately anticipate the folding of a protein based entirely on its amino acid series with 92. 4% precision. That is essential because the way a protein in the human body folds figures out if a pharmaceutical will have the ability to bind to that protein and work.
Historically, this has been a trial-and-error process. And now, Alpha, Fold can predict protein folding with 92. 4% accuracy. That's going to make it a lot easier to create drugs that do what they're developed to do. And here's my next forecast. I predict that Alpha, Fold will be 98% precise by the end of 2021. And we will see not simply one however numerous drug therapies produced utilizing this technology. This was one of those advancements that practically no one saw. But it's going to have extensive implications for treating disease. And, naturally, there will be plenty of financial investment chances in this area, too.
It's going to be a great year for bitcoin. I'm bullish on it in 2021. That stated, I still believe bitcoin will continue to be unstable. We're close to all-time highs. I would not be shocked if it pulled back maybe significantly prior to going greater. I have actually been covering bitcoin for a long time now. Among the first research study reports I ever published was on bitcoin - biotech stocks. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ roi for anyone who followed my recommendation. However at the time of that initial suggestion, I titled my report, "What's the Big Offer With Bitcoin?" That shows you where the conversation was at the time.
But no one is asking that concern anymore. Now, we're seeing institutional cash finally taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some small, specific niche enterprise. exponential growth. Mass, Mutual is a 150-year-old institution. So consider that. In 5 years, we went from informing readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. And that's a big reason I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have another perk forecast In 2021, we're going to have another record year in IPOs. One website reports that Jeff Brown is worth about $27. 5 million and claims the info depends on date since February 2021, but we could not individually confirm this claim. Given Jeff Brown's past, he likely has a substantial net worth, however we can't hammer down a precise figure at this moment. Brown is best known for his sage-like capability to pick winning innovation stocks. He spent more than 25 years researching technology business like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's substantial experience gives him an excellent point of view on the market. He's always on the hunt for new chances, and he shares a lot of his best picks in the Future Report.
That's high appreciation, but it's not ridiculously reasoned. Brown has an outstanding track record as a stock-picker, and he successfully predicted some of the biggest financial events of the past 20 years. Although he does not appear to release his picks to the public, the service's success is a direct indicator of Brown's stock-picking prowess. No one on Wall Street gets it right each time, however Jeff Brown's precise predictions have actually made him legions of devoted followers. That states a lot about his ability. The Near Future Report is released by Brownstone Research study, a prominent financial research publisher. Brownstone Research study uses numerous research services with a variety of specializations - tech stocks.
The company is also associated with Bonner & Partners, another well-respected research study publisher - jeff brown stock market prediction. On its website, Brownstone states its objective is to offer retail financiers with professional-grade research: "For too long, the finest investment research study has not been available to specific financiers. It has been generally reserved for investment banks, hedge funds, personal equity, and high-net-worth customers. jeff brown tech stock 2021. The mission of Brownstone Research study is to make that type of exclusive research available to any financiers seeking to acquire an edge in the marketplaces. The goal is easy to deliver unique and profitable financial investment research found nowhere else." -Brownstone Research website excerpt from the Jeff Brown is the founder of Brownstone Research, and he likewise works as the firm's Chief Investment Analyst.
With Brown directing the ship, Brownstone Research is a powerhouse publisher with lots to offer its clients. After years of consistent success at the helm of top-tier companies like Tesla and Space, X, Elon Musk is a family name throughout the majority of America. If you understand even a little bit about the marketplace, you know that he has a track record as a King Midas of sorts. second wave. Everything he touches turns to gold! Jeff is aware of Elon Musk's executive prowess, so he always has an eye out for the Silicon Valley rock star's next move. This time, Jeff has an early lead on Elon's next big job.
In reality, Brown thinks S.A.V. brownstone research. could be "the most significant trend of the 2020s, and he's not alone. Examine out these quotes from other popular S.A.V. bulls: Elon's next big act will be weding two innovative technologies: artificial intelligence and electrical automobiles. Musk hopes the mix will help him develop the first fully-autonomous, self-driving automobiles ever. It's nothing brief of the vehicle market's Holy Grail. As you understand, electrical cars and self-driving automobile stocks have been big this year, but the Wall Street machine has approved hype without much tangible result. Despite a drastic boost in competitors over the past few years, Brown still believes Musk has the finest chance of putting everything together.
tech might be the magic string that ties everything together. S.A.V. means Shared Autonomous Lorry, and it could be the future of transportation. Generally, this innovation would enable you to lease your vehicle as an autonomous, self-driving taxi when you're not using it. You just leave the car and press a button on an app that tells the cars and truck to "join the fleet." Next thing you know, you're relaxing on your sofa while your vehicle shuttles ride-sharers around town. Best of all, you get to keep a large portion of the profits. It sounds insane, however it might be closed than you believe.